Pinned Tweet
I'm thinking of buying $NBIS for one simple reason.
Today, Nebius is running roughly 20k GPUs.
The plan is ~60k end of FY and ~240k by 2027+
That's a 5x fold increase.
And the CEO has hinted at something even more aggressive: up to 1 GW in 2026
That’s the opportunity.
ABEL is making some MOVES with $BRK.A
Berkshire’s 13F, the first under Abel.
New:
Bending Spoons, 20.69M shares ($689M).
Added:
Lennar nearly doubled to 26.03M shares;
Delta up 12% to 64.45M.
Sold:
Bank of America −5.7%,
VeriSign −34%,
Capital One −62%.
Berkshire was a net seller of $426M of stocks and bought back $9.6B of its own shares.
1
297
So let me get this straight
This WHOLE time everyone tried to convince us that AI is killing SaaS
But now that AI is getting destroyed because of Jensen, SaaS is hit even harder than AI
Make it make sense. Well actually it doesn't which is why the AI will kill SaaS argument is wrong to begin with
16
44
7,305
Here's a stock no one talks about that @BillAckman just bought..
Bill Ackman just disclosed a new 14.7M-share stake in $ALC , a company that dropped about 5% last week after beating on EPS. At $73.64 it trades at about 19x forward earnings.
Here’s what the market sold. Implantables, the lenses used in cataract surgery, fell 2% on competition in the US market. Net sales of $2.72B missed by 0.6%, and management narrowed the full-year growth guide to about 6%. Part of the margin gain came from $58M of tariff refunds.
But one soft product line isn’t the franchise. Core EPS grew 15% to $0.91, consumables grew 6%, ocular health 8%, and nine-month free cash flow rose to $1.35B from $1.24B. Core EPS growth for the year is still guided at 12-14%, and they’ve bought back $748M of stock this year.
If implantables return to growth as newer lenses like PanOptix Pro roll out, this year was a pause and 19x is cheap for 12-14% EPS growth. If US lens competition keeps taking share, Surgical growth stalls and the discount has a reason.
1
6
641
$GOOG just hit its LOWEST P/E the last DECADE
P/E ratio of 14.5
There is some MASSIVE over selling happening right in front of our eyes
$CRM down 10% on NO news?
4
19
3,474
8
2,477
$TSM fell nearly 6% in Taipei and the Taiex dropped about the same, because Nvidia's CEO left.
Here's the bear case, fairly. TSMC is the main maker of Nvidia's AI chips, so a customer in turmoil is a real exposure. The Treasury Secretary wants answers on export controls from Nvidia's board within ten days, Nvidia has asked Taiwan's officials for help after prosecutors accused an employee of helping smuggle AI chips into China, and investors are asking what all this AI spending is actually returning.
But nothing in TSMC's own numbers moved. October revenue was up 59.7% to NT$586.89 billion, and the board raised the quarterly dividend to NT$9.0 from NT$7.0. The stock sits between about 16x and 21x forward earnings depending on whose estimates you use, in a business that takes roughly 73% of contract chipmaking spending.
2
320
This is MASSIVE for $BABA and BEARISH for US labs
$BABA just launched a 2.4-trillion-parameter flagship model, kept it closed, and priced it at $1.50 per million input tokens. Taiwan's market closed down about 6% the same day on AI worries, and Hong Kong traded up.
Here's what the market could be reacting to. China's October retail sales grew just 0.4% against a 0.8% forecast, and industrial output rose 4.8% against 5.3%. Alibaba's AI unit lost RMB 13.9B at the adjusted EBITA level in the June quarter, and free cash flow was negative in five of the last six quarters.
But look at what Qwen4-Max is. Alibaba says it scored near the top of coding benchmarks, and on its own test the average task cost fell from $4.43 to $1.67. Closing the weights means Alibaba wants to be paid for the model, not just downloaded. Before its recent run the stock traded around 12x forward earnings against a five-year average near 13x.
So what for investors: If Thursday's results show cloud and AI revenue growing faster than the AI unit's loss, the spending is investment and this launch is the payoff. If the loss widens while consumer data keeps missing, the cash burn is the story.
$NBIS down 6% pre-market and under $110 is VERY tempting ngl
4
401
This week is MASSIVE for markets, and here are 5 things could move this market in the next 5 days
1. $NVDA reports Tuesday after the close with no permanent CEO. Investors will be looking at whether leadership uncertainty shows up in the guide, and whether the stock can hold up against yields near 5%.
2. Retail sales, $HD and $WMT . Investors will be looking at whether the consumer is still spending after a 0.4% October CPI, and whether the retailers sound more cautious than the headline data.
3. Trump and Xi meet at the APEC summit on 18-19 Nov. Investors will be looking at any signal on chips and trade, which matters directly for the AI names.
4. A possible Anthropic ($ANT) listing, still conditional on completing registration and the offering. Investors will be looking at whether the market has the appetite for a big AI offering at this valuation.
5. Iran and Gulf shipping risk, with Brent having declined. Investors will be looking at whether oil keeps easing, because that is the one thing helping on inflation right now.
Lots of moving pieces, let's see how this goes
1
258
I’ve valued hundreds of companies over the last few years, and I kept running into the same problem:
By the time a stock finally hit my margin of safety, I missed it.
So I’m building buybelow.io to fix it.
Plug in your bear, base, and bull case assumptions, set your buy price, and get an email the moment a stock enters your buy zone.
JOIN the waitlist
buybelow.io solves 3 problems:
1) Pick a stock and look at the numbers that matter
Twenty years of its numbers load in a second.
2) Set 3 cases, easily
Bear, base and bull. Your assumptions, your value.
3) Save to your watchlist
Your values, buy price and reasoning, kept in one place.
4) Get the email
When the price reaches your number, you get notified
3
5
496



















